Literature DB >> 19189052

Chronic granulomatous disease.

B H Segal1, L Romani, P Puccetti.   

Abstract

Chronic granulomatous disease is an inherited disorder of the NADPH oxidase characterized by severe bacterial and fungal infections and disordered inflammation. We propose that NADPH oxidase has a key role in regulating acute neutrophilic and T cell responses, which in turn restrains fungal growth and calibrates the inflammatory response to minimize injury and allergy. In this model, superoxide-induced activation of indoleamine 2,3-dioxygenase (IDO) is a central mechanism by which the optimal balance of antifungal host defense and immune tolerance occurs. This model is based on studies in mice and requires correlation in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189052     DOI: 10.1007/s00018-009-8506-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  10 in total

1.  Generation of a conditional null allele of NADPH oxidase activator 1 (NOXA1).

Authors:  John P Flaherty; Catrina A Spruce; Heather E Fairfield; David E Bergstrom
Journal:  Genesis       Date:  2010-09       Impact factor: 2.487

Review 2.  The mucosal firewalls against commensal intestinal microbes.

Authors:  Andrew J Macpherson; Emma Slack; Markus B Geuking; Kathy D McCoy
Journal:  Semin Immunopathol       Date:  2009-08-26       Impact factor: 9.623

Review 3.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

4.  Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.

Authors:  Felix Meissner; Reinhard A Seger; Despina Moshous; Alain Fischer; Janine Reichenbach; Arturo Zychlinsky
Journal:  Blood       Date:  2010-05-21       Impact factor: 22.113

5.  Functional pseudogenes inhibit the superoxide production.

Authors:  Wei Xu; Li Ma; Wenzhi Li; Tiffany A Brunson; Xiaohua Tian; Jendai Richards; Qiling Li; Tameka Bythwood; Zuyi Yuan; Qing Song
Journal:  Precis Med       Date:  2015

Review 6.  Nox proteins in signal transduction.

Authors:  David I Brown; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

7.  Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy.

Authors:  C R Y Cruz; S Lam; P J Hanley; A S Bear; C Langston; A J Cohen; H Liu; C A Martinez; R A Krance; H E Heslop; C M Rooney; I C Hanson; C M Bollard
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

8.  Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.

Authors:  Janyce A Sugui; Stephen W Peterson; Lily P Clark; Glenn Nardone; Les Folio; Gregory Riedlinger; Christa S Zerbe; Yvonne Shea; Christina M Henderson; Adrian M Zelazny; Steven M Holland; Kyung J Kwon-Chung
Journal:  J Clin Microbiol       Date:  2012-08-01       Impact factor: 5.948

Review 9.  Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005-2015): New Studies and a Literature Review.

Authors:  Jing Wu; Wei-Fan Wang; Yi-Dan Zhang; Tong-Xin Chen
Journal:  J Immunol Res       Date:  2017-01-30       Impact factor: 4.818

10.  A case of chronic granulomatous disease with a necrotic mass in the bronchus: a case report and a review of literature.

Authors:  Ali Cheraghvandi; Majid Marjani; Saeid Fallah Tafti; Logman Cheraghvandi; Davoud Mansouri
Journal:  Case Rep Pulmonol       Date:  2012-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.